KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) announced today that they have been awarded, through their master European distributor, MAVAND Solutions GmbH, a government tender with the French Ministry of Interior. Effective immediately, the police force will begin using ABMC’s patent pending Rapid STAT oral fluid point of collection test to detect the presence or absence of narcotics in French motorists. Based on information contained within the tender, over the next 3 years, ABMC expects the Ministry of Interior to use approximately 900,000 units.
